Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707947
What this trial is testing
Selumetinib for NF2-Related Schwannomatosis
Who this might be right for
Neurofibromatosis Type 2NF2NF2-related Schwannomatosis+3 more
Beijing Tiantan Hospital 20